Skip to main content

Table 3 Baseline imaging parameters of all patients, and patients discriminated with the presence of late gadolinium enhancement (LGE) and segmental wall motion abnormality (SWMA)

From: Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study

 

All patients (n = 86)

LGE negative (n = 25)

LGE positive (n = 61)

p-value

SWMA negative (n = 30)

SWMA positive (n = 56)

p-value

Echocardiography

       

LVEDD, mm

55 (48–61)

48 (44–54)

56 (50–63)

< 0.001

48 (44–54)

59 (53–67)

< 0.001

LVEF, %

50 (33–62)

62 (57–71)

42 (25–56)

< 0.001

63 (60–70)

38 (23–52)

< 0.001

CMR

       

LVEDV, ml/m2

78 (64–110)

71 (60–82)

87 (66–111)

0.050

68 (60–76)

97 (69–120)

< 0.001

LVESV, ml/m2

36 (25–69)

26 (21–32)

46 (30–73)

0.001

25 (20–31)

55 (35–85)

< 0.001

SV, ml

73 (58–85)

75 (65–89)

72 (55–84)

0.227

76 (65–82)

70 (52–88)

0.291

LVEF, %

52 (35–61)

60 (56–69)

45 (32–58)

< 0.001

65 (59–69)

42 (30–53)

< 0.001

LGE presence

61 (71)

-

-

-

9 (30)

52 (93)

< 0.001

LGE extent, score

5 (0–17)

-

9 (4–22)

-

0 (0–2)

11 (4–23)

< 0.001

LGE extent, % LV volume

7 (0–25)

-

13 (6–32)

-

0 (0–3)

16 (6–34)

< 0.001

SWMA, presence

56 (65)

4 (16)

52 (85)

< 0.001

-

-

-

SWMA extent, score

4 (0–12)

0 (0–0)

5 (3–17)

< 0.001

-

7 (4–19)

-

  1. Values are median (IQR) or n (%).
  2. Abbreviations: CMR cardiovascular magnetic resonance, IQR interquartile range, LV left ventricular, LVEF left ventricular ejection fraction, LGE late gadolinium enhancement, LVEDD left ventricle end-diastolic diameter, LVEDV left ventricle end-diastolic volume, LVESV left ventricle end-systolic volume, SV stroke volume, SWMA segmental wall motion abnormality.